Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
7
self-reported band not used
Founded
2006
20 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Description
Medika Natura: Pioneering the Future of Obesity Management in Malaysia
We are pleased to announce a breakthrough achievement by Medika Natura in the field of obesity and metabolic syndrome research.
Our team has successfully completed the FIRST human clinical trial in Malaysia on SKF7®️ (a patented standardized extract of Labisia pumila), revealing its potential as a novel therapeutic treatment for obesity.
Published in the respected Diabetes, Obesity, and Metabolism Journal – a prestigious, peer-reviewed medical publication released monthly – our clinical efforts have undergone meticulous peer review, further enhancing the legitimacy of our discoveries. Boasting an impressive ranking of 31/145 in the Endocrinology & Metabolism (Science) category, this journal underscores the quality, rigor, and significance of our research.
SKF7®️ is derived from Labisia pumila, a native Malaysian medicinal plant widely recognized as Kacip Fatimah. Our study highlights its promising ability to effectively reduce waist circumference and waist-to-height ratio in individuals with obesity, correlated with a reduction in visceral fat among this population. The importance of reducing visceral fat extends beyond aesthetic concerns, as excess visceral fat has been associated with heightened risks of various metabolic diseases, including cardiovascular conditions and diabetes.
We take pride that SKF7®️ has also been granted regulatory clearance by the United States Food and Drug Administration (FDA) as a New Dietary Ingredient. In the same year, 2022, the European Food Safety Authority (EFSA) granted SKF7®️ the status of a Novel Food. These significant accomplishments underscore the safety of SKF7®️ and pave the way for international market expansion. Our dedication was further affirmed with the grant of a patent in 2022, solidifying our position as leaders in obesity research and innovation.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | MY |
All codes: MY
Addresses
- MY44B Jalan Bola Tampar 13/14; Section 13; Shah Alam, Selangor 40100Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at Medika Natura Sdn Bhd?
7 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does Medika Natura Sdn Bhd have offices?
One address on record, Malaysia only. Primary: 44B Jalan Bola Tampar 13/14, Section 13, Shah Alam, Selangor 40100.
Has Medika Natura Sdn Bhd raised funding?
None linked to this brand.
What does Medika Natura Sdn Bhd list as its specialties?
Six tags on the brand's own list, among them healthcare, clinical and natural.
Which companies are listed alongside Medika Natura Sdn Bhd?
18 profiles list Medika Natura Sdn Bhd as a peer — 93rd percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. ABA Pharma Sdn Bhd and Mayflax list it back.